BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26390175)

  • 1. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.
    Meng F; Cheng S; Ding H; Liu S; Liu Y; Zhu K; Chen S; Lu J; Xie Y; Li L; Liu R; Shi Z; Zhou Y; Liu YC; Zheng M; Jiang H; Lu W; Liu H; Luo C
    J Med Chem; 2015 Oct; 58(20):8166-81. PubMed ID: 26390175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
    Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
    Hou Z; Min W; Zhang R; Niu A; Li Y; Cao L; Han J; Luo C; Yang P; Ding H
    Bioorg Med Chem Lett; 2020 May; 30(9):127061. PubMed ID: 32173197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
    Min W; Hou Z; Zhang F; Xie S; Yuan K; Dong H; Wang L; Qi L; Luo C; Ding H; Yang P
    Bioorg Med Chem; 2020 Apr; 28(7):115372. PubMed ID: 32088124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening.
    Ye Y; Zhang B; Mao R; Zhang C; Wang Y; Xing J; Liu YC; Luo X; Ding H; Yang Y; Zhou B; Jiang H; Chen K; Luo C; Zheng M
    Org Biomol Chem; 2017 May; 15(17):3648-3661. PubMed ID: 28397890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, design and synthesis of 6H-anthra[1,9-cd]isoxazol-6-one scaffold as G9a inhibitor through a combination of shape-based virtual screening and structure-based molecular modification.
    Chen WL; Wang ZH; Feng TT; Li DD; Wang CH; Xu XL; Zhang XJ; You QD; Guo XK
    Bioorg Med Chem; 2016 Nov; 24(22):6102-6108. PubMed ID: 27720557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and initial evaluation of affinity-based small molecular probe for detection of WDR5.
    Chen WL; Li DD; Wang ZH; Xu XL; Zhang XJ; Jiang ZY; Guo XK; You QD
    Bioorg Chem; 2018 Feb; 76():380-385. PubMed ID: 29241110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
    Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
    ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9.
    Hamidi T; Singh AK; Veland N; Vemulapalli V; Chen J; Hardikar S; Bao J; Fry CJ; Yang V; Lee KA; Guo A; Arrowsmith CH; Bedford MT; Chen T
    J Biol Chem; 2018 Aug; 293(33):12770-12780. PubMed ID: 29959229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steric structure-activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9.
    Fujiwara T; Ohira K; Urushibara K; Ito A; Yoshida M; Kanai M; Tanatani A; Kagechika H; Hirano T
    Bioorg Med Chem; 2016 Sep; 24(18):4318-4323. PubMed ID: 27448773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
    Gibbons GS; Chakraborty A; Grigsby SM; Umeano AC; Liao C; Moukha-Chafiq O; Pathak V; Mathew B; Lee YT; Dou Y; Schürer SC; Reynolds RC; Snowden TS; Nikolovska-Coleska Z
    Eur J Med Chem; 2020 Mar; 189():112023. PubMed ID: 31978781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
    Takemoto Y; Ito A; Niwa H; Okamura M; Fujiwara T; Hirano T; Handa N; Umehara T; Sonoda T; Ogawa K; Tariq M; Nishino N; Dan S; Kagechika H; Yamori T; Yokoyama S; Yoshida M
    J Med Chem; 2016 Apr; 59(8):3650-60. PubMed ID: 27088648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines.
    Kondengaden SM; Luo LF; Huang K; Zhu M; Zang L; Bataba E; Wang R; Luo C; Wang B; Li KK; Wang PG
    Eur J Med Chem; 2016 Oct; 122():382-393. PubMed ID: 27393948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.
    Chen S; Wang Y; Zhou W; Li S; Peng J; Shi Z; Hu J; Liu YC; Ding H; Lin Y; Li L; Cheng S; Liu J; Lu T; Jiang H; Liu B; Zheng M; Luo C
    J Med Chem; 2014 Nov; 57(21):9028-41. PubMed ID: 25333769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
    Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
    Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the methylation site specificity of SET7/9.
    Couture JF; Collazo E; Hauk G; Trievel RC
    Nat Struct Mol Biol; 2006 Feb; 13(2):140-6. PubMed ID: 16415881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
    Chen J; Park HJ
    ACS Chem Biol; 2019 May; 14(5):873-881. PubMed ID: 30951287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase.
    Butler KV; Ma A; Yu W; Li F; Tempel W; Babault N; Pittella-Silva F; Shao J; Wang J; Luo M; Vedadi M; Brown PJ; Arrowsmith CH; Jin J
    J Med Chem; 2016 Nov; 59(21):9881-9889. PubMed ID: 27804297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.